Alibaba Health Information Technology has a current ratio of 3.03. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
ALBBY's Current Ratio is ranked better than 77.5% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs ALBBY: 3.03
Alibaba Health Information Technology (OTCPK:ALBBY) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Alibaba Health Information Technology Current Ratio Related Terms
Alibaba Health Information Technology Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Current Ratio Chart
Alibaba Health Information Technology Current Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Current Ratio distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology (ALBBY) has a Current Ratio of 3.03 as of Mar. 2026. This is 11% above median its historical median of 2.72. Over the past decade, Alibaba Health Information Technology's Current Ratio has ranged from 1.02 to 4.18. According to the industry distribution chart, Alibaba Health Information Technology ranks #153 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 22.5%.
Is Alibaba Health Information Technology's Current Ratio too high?
Alibaba Health Information Technology's current Current Ratio of 3.03 is 11% above median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 4.18. The Healthcare Providers & Services industry median Current Ratio is 1.47. Alibaba Health Information Technology's value of 3.03 is 106.1% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #153 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Current Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #153 out of 680 companies for Current Ratio. This places Alibaba Health Information Technology in the top 23% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. Alibaba Health Information Technology's value of 3.03 is 106.1% above this benchmark. Historically, Alibaba Health Information Technology's own Current Ratio has ranged from 1.02 to 4.18 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 1.47, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Current Ratio of 3.03 is 106.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Current Ratio is 3.03, which is 11% above median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $13.36, compared to a current price of $7.92 — trading 40.7% below its estimated fair value. The current Current Ratio is 3.03, which is 11% above median its 10-year median of 2.72 and 106.1% above the Healthcare Providers & Services industry median of 1.47. Alibaba Health Information Technology's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBBY), the current Current Ratio is 3.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $7.92 is trading 40.7% below its estimated GF Value™ of $13.36.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBBY:
Current Ratio: 3.03 (11% above median its 10-year median of 2.72)
GF Value™: $13.36 vs. price of $7.92 (40.7% below fair value)
Industry Position: 106.1% above the Healthcare Providers & Services median (#153 of 680)
No single metric tells the full story. See the ALBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
73GF Score
Get the complete analysis for ALBBY
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBBY has been successfully added to your 
